Event: IP Strategies for Health Sciences Startups | Harvard…
Skip to content

Apr 01, 2014

IP Strategies for Health Sciences Startups

IP Strategies for Health Sciences Startups

Biotechnology and medical device companies are heavily dependent upon intellectual property rights, particularly those developing diagnostic, therapeutic or invasive products, because the investment required for R&D and regulatory review of biotech and medical device products and services is typically far greater than for innovations relating to other mechanical engineering, electrical engineering or consumer products. In addition, the complexity of the technology and the rapidly evolving legal landscape make the availability, validity and enforceability of biotech patents highly uncertain.

This session, led by Michael Twomey, a patent attorney and partner at WilmerHale, will explore some of the basic intellectual property questions facing biotech and medical device start-ups: When should you file a patent application? How can you minimize cost and maximize value? What patent filing and prosecution strategy is right for you? How do you avoid self-inflicted wounds? What are the legal and practical limitations of IP protection? How do you avoid infringing third party patent rights? How should you work with your patent attorney?

Brought to you by Harvard i-lab and the Harvard Stem Cell Institute


We check all attendee registrations at the door. Please bring a printed or smartphone copy of your EventBrite registration and Harvard student ID if you have registered as a Harvard Student. Attendance will be limited to registered guests and tickets will not be available at the door.

Note: Harvard Shuttles have a stop directly across from the i-lab, and you can track the shuttles online here: http://harvard.transloc.com/ If you are driving, please park in the i-lab's lot (entrance on Western Avenue, directions and payment information are here: http://i-lab.harvard.edu/parking).